Dupilumab-associated hypereosinophilia in severe asthma.

April Strong Tiffany LinAsger SverrildAnna MackayJoy Wei-Yan LeeCelia ZubrinichJonathan Pham Julian J BoscoEve DentonMonique DolsRobert G StirlingEli DabscheckJhanavi IyerAndrew GillmanMark Hew

Published in: ERJ open research (2024)

Dupilumab has been associated with adverse reactions including symptomatic hypereosinophilia. This study reports the incidence of dupilumab-related eosinophilia and adverse reactions in severe asthma patients at an Australian tertiary centre. https://bit.ly/3JgZ5Ya.

Keyphrases

atopic dermatitis
adverse drug
risk factors
emergency department
drug induced